Teriflunomide in relapsing multiple sclerosis: therapeutic utility

Por Freedman, Mark S.
Publicado em 2013

Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis

Por Freedman, Mark S
Publicado em 2014

Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome

Por Freedman, Mark S.
Publicado no Ther Adv Neurol Disord (2014)

Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned

Por Atkins, Harold L., Freedman, Mark S.
Publicado em 2012

Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases

Por D’Ambrosio, Daniele, Freedman, Mark S., Prinz, Joerg
Publicado no Ther Adv Chronic Dis (2016)

HIV risks and testing behavior among Asians and Pacific Islanders: results of the HIV Testing Survey, 2002-2003.

Por Kahle, Erin M., Freedman, Mark S., Buskin, Susan E.
Publicado em 2005

Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis

Por Freedman, Mark S, Kaplan, Johanne M, Markovic-Plese, Silva
Publicado em 2013

Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-infected Men Who have Sex with Men in the United States

Por Lin, Xia, Mattson, Christine L., Freedman, Mark, Skarbinski, Jacek
Publicado no AIDS Behav (2017)

Tests of Information Processing Speed: What Do People with Multiple Sclerosis Think About Them?

Por Walker, Lisa A.S., Cheng, Amy, Berard, Jason, Berrigan, Lindsay I., Rees, Laura M., Freedman, Mark S.
Publicado em 2012

Routine HIV Testing among Providers of HIV Care in the United States, 2009

Por McNaghten, A. D., Valverde, Eduardo E., Blair, Janet M., Johnson, Christopher H., Freedman, Mark S., Sullivan, Patrick S.
Publicado em 2013

Pain due to multiple sclerosis: Analysis of the prevalence and economic burden in Canada

Por Piwko, Charles, Desjardins, Olivier B, Bereza, Basil G, Machado, Marcio, Jaszewski, Barbara, Freedman, Mark S, Einarson, Thomas R, Iskedjian, Michael
Publicado em 2007

Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis

Por Costello, Fiona, Hodge, William, Pan, Y. Irene, Burton, Jodie M., Freedman, Mark S., Stys, Peter K., Trufyn, Jessie, Kardon, Randy
Publicado em 2012

Using the U.S. National Household Travel Survey to estimate the impact of passenger characteristics on young drivers’ relative risk of fatal crash involvement

Por Ouimet, Marie Claude, Simons-Morton, Bruce G., Zador, Paul L., Lerner, Neil D., Freedman, Mark, Duncan, Glen D., Wang, Jing
Publicado em 2009

Excess Burden of Depression among HIV-Infected Persons Receiving Medical Care in the United States: Data from the Medical Monitoring Project and the Behavioral Risk Factor Surveill...

Por Do, Ann N., Rosenberg, Eli S., Sullivan, Patrick S., Beer, Linda, Strine, Tara W., Schulden, Jeffrey D., Fagan, Jennifer L., Freedman, Mark S., Skarbinski, Jacek
Publicado em 2014

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis

Por Bar-Or, Amit, Freedman, Mark S., Kremenchutzky, Marcelo, Menguy-Vacheron, Françoise, Bauer, Deborah, Jodl, Stefan, Truffinet, Philippe, Benamor, Myriam, Chambers, Scott, O’Connor, Paul W.
Publicado em 2013

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial

Por Olsson, Tomas, Boster, Aaron, Fernández, Óscar, Freedman, Mark S, Pozzilli, Carlo, Bach, Doris, Berkani, Ouali, Mueller, Markus S, Sidorenko, Tatiana, Radue, Ernst-Wilhelm, Melanson, Maria
Publicado em 2014

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

Por Confavreux, Christian, Li, David K, Freedman, Mark S, Truffinet, Philippe, Benzerdjeb, Hadj, Wang, Dazhe, Bar-Or, Amit, Traboulsee, Anthony L, Reiman, Lucy E, O’Connor, Paul W
Publicado em 2012

Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis

Por Miller David H, Edan Gilles, Freedman Mark S, Barkhof Frederik, Polman Chris H, Pohl Christoph, Nielsen Jessica M, Bauer Lars, Sandbrink Rupert, Kappos Ludwig, Uitdehaag Bernard MJ
Publicado em 2011-02-01

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

Por Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ
Publicado em 2009

Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis

Por Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ
Publicado em 2011